RTOG-0232

A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone for Selected Patients with Intermediate Risk Prostatic Carcinoma

Principal Investigator

Bradley R. Prestidge

Status

Disease Site

Genitourinary [GU] Prostate

Phase

III

Developmental Therapeutics

No

Primary Objective

To determine whether combined external beam radiation (EBRT) and transperineal interstitial permanent brachytherapy will result in better freedom from progression (FFP) for 5 years compared to brachytherapy alone among selected patients with intermediate risk prostatic carcinoma.

Patient Population

Patients with locally confined adenocarcinoma of the prostate.

Target Accrual

586